Newsroom

SAN CARLOS, Californie--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq : ONC ; HKEX : 06160 ; SSE : 688235), une société mondiale spécialisée en oncologie, fait évoluer le paradigme thérapeutique de la leucémie lymphoïde chronique (LLC) lors du congrès annuel 2026 de l’American Society of Clinical Oncology (ASCO). Grâce à un suivi à long terme approfondi, l’étude SEQUOIA sur BRUKINSA® (zanubrutinib) renforce son rôle d’inhibiteur de BTK de référence, démontrant un contrôle durable de la maladie...

CHICAGO--(BUSINESS WIRE)--As theranostics adoption acceleratesi and radiopharmaceutical demand grows,ii healthcare systems are under increasing pressure to scale nuclear medicine operations while improving diagnostic confidence and workflow efficiency. At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare showcases its latest technologies and AI-enabled workflows to help support precision care across care pathways. Nuclear medicine is undergoing rap...

SAN DIEGO--(BUSINESS WIRE)--Avenzo Therapeutics Presents Updated Results from Phase 1/2 Study of AVZO-021, a Potentially Differentiated CDK2 Inhibitor, at ASCO Annual Meeting...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx NextG UCITS ETF 29.05.2026 NXTG.LN IE00BWTNM743 170,002.00 USD 9,900,303.52 58.236  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones International Internet UCITS ETF 29.05.2026 FDNI.LN IE00BT9PVG14 450,002.00 USD 8,173,856.67 18.164  ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--SmartBear, helping teams build, test, and ship quality software at AI speed and scale, today announced the first platform to unify property-based, OCR, and vision AI — expanding coverage, reducing risk, and perceiving applications the way humans do. This functionality will automate testing of highly visual applications that are traditionally tested manually because of their complexity, leading to poorer coverage and increased risk exposure. Automating testing...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Barings BDC, Inc. (NYSE: BBDC) (“Barings BDC” or the “Company”) today announced the early termination of its existing credit support agreement (“original CSA”) associated with the Company’s acquisition of Sierra Income Corporation (“Sierra”), and the implementation of a new credit support agreement covering the remaining investments in two Sierra legacy portfolio companies. The original CSA, entered into on February 25, 2022 in connection with the Sierra merger...

DURHAM, N.C.--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced the launch of its PrEP Wisdom campaign, designed to empower people to make informed decisions about long-acting injectable (LAI) HIV prevention, beyond the dosing schedules. The campaign features TV personality Michelle Visage, a long-time HIV and LGBTQ advocate. Approximately 2.2 million people in the US could benefit from pre-exposure prophyl...

NEW YORK--(BUSINESS WIRE)--Tradewinds Universal (OTC: TRWD), a holdings company executing a consolidation strategy in the experiential hospitality sector, today announced the relocation of its corporate headquarters to Las Vegas, Nevada, effective June 1, 2026. Effective June 1, 2026, TRWD’s principal corporate offices will be located at 1531 S Las Vegas Blvd, Las Vegas, NV 89104, the headquarters of Peppermint Hippo. The relocation reflects the deepening relationship between Tradewinds Univers...

NEW HAVEN, Conn. & SAN DIEGO, Calif.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) ("Rallybio") and Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced that they have entered into a definitive agreement pursuant to which Rallybio will acquire Avenzo through a merger transaction (the "Merger"). Upon completion of the Merger, the combined company is expected to operate under the name Avenzo Therapeutic...